Immunochina Competitors and Similar CompaniesClear all
Immunochina's competitors and similar companies include Divide & Conquer.
 Immunochina Immunochina is a company that specializes in applying CAR-T technology and gene cell drugs to the treatment of malignant tumors. |  Divide & Conquer Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy. | |
Founding Date | Founding Date 2015 | Founding Date 2018 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations CN HQ | Locations Babraham, GB HQ |
Employees | Employees 205% increase | Employees 2 |
Funding | ||
Latest funding round | Latest funding round $ 20.6m (over 7 years ago) | Latest funding round $ 12.5m (over 6 years ago) |
Total funding raised | Total funding raised $ 28.1m | Total funding raised $ 12.5m |
For sources of this data, please see the company profile
View Company Profiles
Divide & Conquer
HQ
Babraham, GB
Employees
2
Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy.
View company